Getting The Deal Through logo
Getting The Deal Through


Corporate Counsel Q&A – Iain Ward, GW Pharma

Pharma - Features – 06 November 2018

On 1 November, cannabis-based epilepsy treatment Epidiolex went on sale throughout the US, having become the first drug incorporating non-synthetic cannabidiol to win FDA approval over the summer. In our latest in-house Q&A, PLN caught up with Epidiolex manufacturer GW Pharmaceutical’s general counsel Iain Ward.


Corporate counsel Q&A: Stathis Mihos, Pfizer

Pharma - Features – 18 September 2018

As part of our ongoing series of interviews with in-house lawyers at international pharma companies, PLN caught up with Stathis Mihos – Pfizer’s legal director and Greece, Cyprus, Malta, Israel and Adriatic sub-cluster lead – to discuss the challenges of doing business in the region and the company’s unique approach to working with outside counsel.


Corporate counsel Q&A: Alejandro Torrendell, Merck

Pharma - Features – 04 September 2018

In the first of a new occasional series of interviews, PLN speaks to Merck’s general counsel for Latin America Alejandro Torrendell about in-house life at a pharma company in the region and how his department stays ahead of the curve.


ABA Life Sciences Conference: international perspectives on drug pricing (part 2)

Pharma - Features – 17 July 2018

The American Bar Association’s Section of International Law hosted its 2018 Life Sciences Conference in Copenhagen last month, including, among other sessions, a detailed panel discussion of drug pricing practices around the world.


ABA Life Sciences Conference: international perspectives on drug pricing (part 1)

Pharma - Features – 10 July 2018

Drug pricing is a “pivotal point” for the pharmaceuticals industry, where the high cost of innovation often comes into conflict with the political drive to keep prices down, according to an array of international speakers who offered local snapshots of recent developments at a conference held by the American Bar Association’s Section of International Law in Copenhagen last month.


ABA Life Sciences Conference: dealing in data

Pharma - Features – 12 June 2018

The American Bar Association’s Section of International Law opened its 2018 life sciences conference in Copenhagen on 11 June with discussions of how big data, and its regulation in Europe under the new General Data Protection Regulation (GDPR), is driving change and disruption in the industry






Follow Getting the Deal Through for the latest updates on law and regulation worldwide

Follow us on LinkedIn